Cited by 1,024Neurological disorders and treatmentsObsessive-Compulsive Spectrum DisordersTreatment of Major Depression

Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression

Open access
Lozano, Andres M., Mayberg, Helen S., Giacobbe, Peter, Hamani, Clement, Craddock, R. Cameron, Kennedy, Sydney H.·2008·Biological Psychiatry

Abstract

Background A preliminary report in six patients suggested that deep brain stimulation (DBS) of the subcallosal cingulate gyrus (SCG) may provide benefit in treatment-resistant depression (TRD). We now report the results of these and an additional 14 patients with extended follow-up.Methods Twenty patients with TRD underwent serial assessments before and after SCG DBS. We determined the percentage of patients who achieved a response (50% or greater reduction in the 17-item Hamilton Rating Scale for Depression [HRSD-17]) or remission (scores of 7 or less) after surgery. We also examined changes in brain metabolism associated with DBS, using positron emission tomography.Results There were both early and progressive benefits to DBS. One month after surgery, 35% of patients met criteria for response with 10% of patients in remission. Six months after surgery, 60% of patients were responders and 35% met criteria for remission, benefits that were largely maintained at 12 months. Deep brain stimulation therapy was associated with specific changes in the metabolic activity localized to cortical and limbic circuits implicated in the pathogenesis of depression. The number of serious adverse effects was small with no patient experiencing permanent deficits.Conclusions This study suggests that DBS is relatively safe and provides significant improvement in patients with TRD. Subcallosal cingulate gyrus DBS likely acts by modulating brain networks whose dysfunction leads to depression. The procedure is well tolerated and benefits are sustained for at least 1 year. A careful double-blind appraisal is required before the procedure can be recommended for use on a wider scale.

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2008.05.034

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Open-label trials of subcallosal cingulate cortex DBS for treatment-resistant depression have shown response rates around 55-66% and remission rates around 33-40% at 6-12 months.

    “The first open-label trial of DBS for TRD conducted by Mayberg et al. demonstrated its safety and efficacy, with a response rate (RS) at 6 months of 66% and remission (RM) rate of 33% [5].”

    From Deep brain stimulation for depression. (2022) · cites this paper as [23]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lozano, A. M., Mayberg, H. S., Giacobbe, P., Hamani, C., Craddock, R. C., & Kennedy, S. H.
Affiliations
  • Emory University (US)
  • University of Toronto (CA)
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2008-09
Volume
64
Issue
6
Pages
461-467
ISSN
0006-3223 (ISSN-L)
OpenAlex
W2132969335
Cited by
1,024
References
25
Citations by year
2026: 34 · 2025: 34 · 2024: 37 · 2023: 37 · 2022: 38 · 2021: 57 · 2020: 46 · 2019: 52 · 2018: 56 · 2017: 46 · 2016: 54 · 2015: 73 · 2014: 75 · 2013: 77 · 2012: 88
FWCI
45.77
Type
journal article
Language
en
Open access
Locations
  • Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Alliance for Research on Schizophrenia and Depression
Topics
  • Health Sciences › Medicine › Neurology › Neurological disorders and treatments
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
deep brain stimulation, treatment-resistant depression, depression remission, brain metabolism, limbic circuits, adverse effects, long-term outcomes
MeSH terms
Cerebral Cortex, Corpus Callosum, Major Depressive Disorder, Drug Resistance, Female, Glucose, Gyrus Cinguli, Humans, Limbic System, Magnetic Resonance Imaging, Male, Middle Aged, Surveys and Questionnaires, Severity of Illness Index, Stereotaxic Techniques, Neurosurgical Procedures, Deep Brain Stimulation, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review